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Abstract
Hyperspectral imaging (HSI) systems have the 
potential to retrieve in vivo hemodynamic and 
metabolic signals from the exposed cerebral 
cortex. The use of multiple narrow wavelength 
bands in the near infrared (NIR) range theoreti-
cally allows not only to image brain tissue oxy-
genation and hemodynamics via mapping of 
hemoglobin concentration changes, but also to 
directly quantify cerebral metabolism via mea-
surement of the redox states of mitochondrial 
cytochrome-c-oxidase (CCO). The aim of this 
study is to assess the possibility of performing 
hyperspectral imaging of in vivo cerebral oxy-
hemoglobin (HbO2), deoxyhemoglobin (HHb) 
and oxidized CCO (oxCCO) using commer-
cially available HSI devices. For this reason, a 
hyperspectral snapshot solution based on 
Cubert GmbH technology (S185 FireflEYE 
camera) has been tested on the exposed cortex 
of mice during normoxic, hypoxic and hyper-
oxic conditions. The system allows simultane-
ous acquisition of 138 wavelength bands 
between 450 and 998 nm, with spectral sam-
pling and resolution of ~4 to 8 nm. From the 
hyperspectral data, relative changes in concen-
tration of hemoglobin and oxCCO are esti-
mated and hemodynamic and metabolic maps 
of the imaged cortex are calculated for two dif-
ferent NIR spectral ranges. Spectroscopic anal-
ysis at particular regions of interest is also 
performed, showing typical oxygen-dependent 
hemodynamic responses. The results highlight 
some of the potentials of the technology, but 
also the limitations of the tested commercial 
solution for such specific application, in par-
ticular regarding spatial resolution.
1  Introduction
Hyperspectral imaging (HSI) is an optical modal-
ity that involves the acquisition of images at 
numerous contiguous wavelength bands across a 
broad portion of the electromagnetic spectrum. 
Such images then form a three-dimensional (3D) 
spatio-spectral dataset (x, y, λ), known as 
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 hypercube, where a complete spectrum is associ-
ated with each pixel of the imaged target [1].
In recent years, HSI has emerged as a promis-
ing imaging technology for biomedical applica-
tions and life science research, targeting different 
biological processes and several types of tissues 
[1]. In particular, it has shown the capability to 
retrieve quantitative information on in vivo brain 
tissue oxygenation and hemodynamics in both 
small animals and humans, by measuring changes 
in reflected light intensity at different spectral 
bands, in the visible and near-infrared (NIR) 
range [2, 3]. These intensity changes can be 
tracked back to modifications in the absorption 
properties of the imaged tissues during changes in 
oxygenation and blood perfusion, due to varia-
tions in the relative concentrations of the two 
states of hemoglobin, i.e. oxygenated (HbO2) and 
deoxygenated (HHb). Furthermore, HSI could 
also potentially be used to monitor in vivo cere-
bral metabolism, by targeting a third chromo-
phore that takes part in cellular respiration and 
energy production, namely cytochrome-c- oxidase 
(CCO) and its redox forms [4]. This is possible 
via the detection of the optical spectral signature 
of the copper CuA redox centre of CCO, which is 
predominant in the NIR range between 780 and 
900 nm [4, 5]. It has been also demonstrated [6, 7] 
that employing a large number of wavelengths 
over such relatively broad spectral range signifi-
cantly improves the signal-to-noise ratio (SNR) of 
the data and enhances discrimination between the 
CCO and hemoglobin signals. Thus, HSI appears 
as particularly suited for imaging the hemody-
namic and metabolic states of the brain, such as 
the exposed cerebral cortex of small animals.
In this study, the feasibility and potential of 
HSI for brain hemodynamic and metabolic moni-
toring are explored. In particular, the performance 
of a commercial snapshot hyperspectral solution 
is evaluated, focusing on its suitability to be 
employed on the exposed cerebral cortex of mice.
2  Materials and Methods
A hyperspectral snapshot camera based on Cubert 
GmbH technology (the S185 FireflEYE [8]) was 
chosen for the study, due to its technical 
 characteristics: primarily, the number of wave-
length bands (138) and its spectral resolution (~4 
to 8 nm) and sampling (4 nm). The specifications 
of the camera are summarized in Table 1.
The snapshot acquisition mode for HSI 
involves the simultaneous collection of every 
image at each spectral band, within a single inte-
gration time of the detector [1, 9]. This approach 
is preferred due to the benefits it provides for 
in vivo imaging, i.e. fast acquisition rate and low 
susceptibility to motion artifacts [9]. The S185 
FireflEYE camera performs the snapshot acquisi-
tion mode by employing two charge-coupled 
device (CCD) detectors, together with a pinhole 
and prisms for spatial and spectral separation, 
respectively. The spatial and the spectral infor-
mation are then combined by an interpolation 
algorithm to obtain the final hypercube.
The setup used for the HSI study on the 
exposed cortex of mice is shown in Fig. 1a. A 4× 
achromatic objective coupled with two achro-
matic doublet lenses are implemented in front of 
the S185 FireflEYE snapshot camera, in order to 
achieve a field of view (FOV) of about 4 × 4 mm. 
A broadband white light source (Ocean Optics 
HL-2000-FHSA) was then utilised for the illumi-
nation, directing it with a fibre optic needle. The 
FOV and spatial resolution of the setup were then 
estimated by imaging a calibrated spatial resolu-
tion phantom.
The hyperspectral setup described above was 
tested on the exposed cerebral cortex of anesthe-
tized (1.5% isoflurane) healthy mice breathing 
normoxic, hyperoxic and several hypoxic gas 
mixtures in oxygen and nitrogen. These oxygen- 
dependent levels were established by manipulat-
ing the fraction of inspired oxygen (FiO2) of the 
Table 1 Technical characteristics of the S185 FireflEYE 
snapshot camera [8]
Specifications Cubert S185 FireflEYE
Acquisition mode: Snapshot
Spatial resolution: 1000 × 1000 pixels
Spectral range: 450–998 nm
Spectral bands: 138
Spectral sampling: 4 nm
Spectral resolution 
(FWHM):
8 nm at 532 nm
Hypercube rate Up to 5 hypercubes/s
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mice. The experimental protocol consisted of the 
following consecutive phases: normoxic baseline 
(FiO2  =  21%); hyperoxia (FiO2  =  100%); nor-
moxia (FiO2 = 21%); hypoxia (FiO2 = 15%); nor-
moxia (FiO2  =  21%); hypoxia (FiO2  =  10%); 
normoxia (FiO2 = 21%); hypoxia (FiO2 = 5%); 
and death (FiO2  =  0%). During the normoxic 
baseline, 400 hypercubes were acquired for 
2 min, at 0.3 s delay between each cube. For each 
of the following phases, 1000 hypercubes were 
acquired for 5 min, again at 0.3 s delay. Complete 
hypercubes for both the white reference, using a 
white reflectance standard, and the dark refer-
ence, by covering the lens of the camera, were 
also recorded using the same exposure times used 
for the experimental phases.
After data collection, the acquired hypercubes 
of each phase and of the white reference were cor-
rected by subtracting the dark reference hypercube 
from each of them. Normalization to the white 
reflectance was then performed for each of the 
hypercubes of the exposed cortex, by dividing 
them for the white reference hypercube. The cor-
rected hypercubes were then integrated over time, 
to improve SNR. The 400 hypercubes of the nor-
moxic baseline were time-averaged over their 
whole 2-min acquisition time. For the 1000 hyper-
cubes of each following phase, time- averaging 
was performed for every 100 hypercubes, obtain-
ing ten time-averaged hypercubes per each condi-
tion (every 30 s during the experimental phases).
Finally, the time-averaged hypercubes were 
used to estimate the 2D maps of the relative 
changes in concentrations (per unit pathlength) 
Δ[HbO2], Δ[HHb] and Δ[oxCCO] at different 
time intervals. These maps were calculated by 
applying, pixel by pixel, the modified Beer- 
Lambert’s law [10], assuming a unitary differen-
tial pathlength (DPF = 1). Reference spectra for 
the molar extinction coefficients of hemoglobin 
and the oxidized-reduced molar extinction spec-
trum for CCO were all obtained from UCL 
Biomedical Optics Research Laboratory (BORL) 
database [11].
Fig. 1 (a) Picture of the setup used for the investigation 
with the hyperspectral snapshot solution, highlighting the 
major components; (b) RGB microscope picture of the 
exposed cerebral cortex; (c) Spectrally averaged image of 
the same cortex, acquired during normoxic baseline; (d) 
hyperspectral image of the exposed cortex at 650 nm; (e) 
hyperspectral image of the exposed cortex at 750 nm
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Two sets of maps were obtained using the 
hyperspectral data at different spectral ranges: (1) 
between 778 and 902 nm (32 wavelength bands), 
aiming at resolving both the hemodynamic and 
the metabolic response from the HbO2, HHb and 
CCO signals; and (2) between 650 and 986 nm 
(85 wavelength bands), considering only the 
hemoglobin signal, as to enhance visualisation of 
the hemodynamic response. The full range of the 
camera was not utilised for this last calculation 
due to the excessive amount of noise in the hyper-
cubes below 650  nm. Differential spectroscopy 
analysis was also conducted on regions of inter-
est (ROI) of the exposed cortex, in particular 
within the major vessels and the surrounding tis-
sue. This was achieved by spatially averaging the 
concentration changes across all the selected 
ROIs in the two sets of maps, in order to obtain 
the averaged temporal variations of Δ[HbO2], 
Δ[HHb] and Δ[oxCCO] in these ROIs during the 
different phases.
3  Results
Figure 1b shows a red-blue-green (RGB) picture 
of the exposed cortex of one of the mice, taken 
with a surgical microscope. Figure  1c presents 
the monochrome image obtained from the HSI 
setup during normoxic baseline, by spectrally 
integrating all the wavelength bands (138) in the 
hypercube. The exposure time for this image was 
set to 40 ms. It can be seen that the monochrome 
image provides good spatial resolution and 
details, compared with the colour image of the 
cortex: both major vessels (estimated size of 
~150 μm), as well as the smaller ones (~50 to 
60 μm), are resolved. However, by looking at the 
images at single spectral bands (as shown in 
Fig. 1d, e, depicting the target at 650 and 750 nm, 
respectively), image contrast appears consider-
ably lower, with only the major vasculature 
resolved. The images at single bands also display 
a significant amount of noise. Furthermore, the 
reflectance spectra of the pixels of the hyper-
cubes present less smooth profiles compared with 
the typical intensity spectra obtained in broad-
band NIR spectroscopy.
To try to overcome these issues, the exposure 
time was increased to 70  ms for the following 
mouse, pushing the intensity of the reflected light 
almost to the saturation value of the camera, in 
order to increase image SNR as much as possi-
ble. Results of Δ[HbO2], Δ[HHb] and Δ[oxCCO] 
for such configuration in the range 778–902 nm 
are shown in Fig. 2, for the last hypoxic condition 
(FiO2 from 5% to death). Image contrast in these 
maps is low: however, the time progression of the 
hemodynamic response on the major vessels can 
be localised for HbO2 and HHb, although it 
appears blurred and spread also outside the vas-
culature. The map of oxCCO results even much 
noisier and only a very slight localisation of the 
metabolic response is possible. Spatial resolution 
is also limited to indistinct shapes of the 
vasculature.
The spectroscopic analysis of the ROI inside 
the major vasculature (Fig. 3) provides results 
consistent with the expected hemodynamic 
response of HbO2 and HHb for all the phases. 
The magnitude of this response is considerably 
lower for the ROI in the surrounding tissue 
(Fig. 4), as predicted, and it only increases in 
the last phases, possibly because of spreading 
outside the vessels. Changes in oxCCO are 
observed in both ROIs (even the one within the 
vessels), although due to the significant amount 
of noise in the corresponding map, it is diffi-
cult to attribute these changes to actual physi-
ological and metabolic variations in the brain 
tissue.
Finally, Fig. 5a presents the calculated maps 
of only Δ[HbO2] and Δ[HHb] in the broader 
NIR range (650–986 nm). Spatial resolution of 
these maps appears significantly higher, with 
detailed visualisation of the larger vasculature, 
as well as of the smaller one. The hemodynamic 
response is also more clearly resolved and local-
ised, especially for HHb. This is supported by 
the expected results of the related spectroscopic 
analysis of the ROI inside the major vessels, as 
reported in Fig. 5b.
No quantification of the depth of the measure-
ments in the brain tissue was possible, due to lack 
of estimate of the differential optical pathlength, 
as mentioned.
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4  Discussion and Conclusions
The results of the study have highlighted some of 
the major advantages of HSI technologies and of 
the commercial snapshot solution, but some of 
the drawbacks and limitations of the tested instru-
ment for in  vivo brain metabolic monitoring in 
small animals are also apparent. In particular, the 
tested HSI solution has shown its capability to 
localise the hemodynamic response in the 
exposed cortex from all the maps. Furthermore, 
the spectroscopic analysis retrieved correct time- 
varying hemodynamic information from the 
exposed cortex under different oxygen- dependent 
conditions. However, although the spatial 
 resolution of the maps was adequate for the range 
650–986 nm, it was not high enough for imaging 
all the vasculature details in the selected range 
for the CCO signal (778–902 nm). Better focus-
ing and magnification may be necessary to 
achieve this goal and to improve image quality. 
Therefore, this limited spatial resolution makes 
impossible to assess the correct evaluation of the 
metabolic response. Indeed, a better spatial reso-
lution is required to minimize image noise, in 
order to discern the focalised and smaller changes 
in oxCCO (about ten times lower than hemoglo-
bin) in the specific NIR wavelength interval.
Fig. 2 Maps of the relative concentration changes (per 
unit pathlength) in HbO2 (b), HHb (c) and oxCCO (d) in 
the exposed cerebral cortex during transition from hypoxia 
to death (FiO2 from 5% to 0%), analysed in the spectral 
range between 778 and 902 nm. The maps are compared 
with the spectrally averaged image of the same cortex, 
acquired during normoxic baseline (a)
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Fig. 3 Spectroscopic analysis of a ROI including a major 
vessel of the exposed cortex, showing the temporal 
changes Δ[HbO2] (red), Δ[HHb] (blue) and Δ[oxCCO] 
(green), in the spectral range between 778 and 902 nm, 
during all the different oxygen-dependent conditions of 
the experiment
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Fig. 4 Spectroscopic analysis of a ROI in the tissue out-
side major vessels of the exposed cortex, showing the 
temporal changes Δ[HbO2] (red), Δ[HHb] (blue) and 
Δ[oxCCO] (green), in the spectral range between 778 and 
902 nm, during all the phases of the experiment
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Furthermore, the selection of the spectral 
range for the metabolic analysis of CCO is funda-
mental, since different redox complexes of CCO 
contribute differently to its optical signatures in 
the visible and NIR range: among them are the 
heam iron centres (cytochrome a and a3), the cop-
per CuB centre, as well as intermediate oxygen-
ated forms of CCO (namely P and F) [5]. The 
aforementioned compounds also show different 
responses to metabolic changes. Accurate HSI 
analysis of these spectral signatures could pro-
vide a more comprehensive overview of brain 
metabolism.
Considering the previous points, the current 
commercial HSI setup was found not suitable for 
in vivo metabolic monitoring, without some cus-
tomising steps. Therefore, we are currently inves-
tigating bespoke solutions for HSI of the exposed 
cortex.
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Fig. 5 (a) Recalculated hemodynamic maps of Δ[HbO2] 
(left) and Δ[HHb] (right) for the spectral range 650–
986  nm. (b) Spectroscopic analysis of a ROI from the 
above maps that includes a major vessel of the exposed 
cortex, showing the temporal changes of Δ[HbO2] (red) 
and Δ[HHb] (blue)
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